DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Loviride
Loviride
Failure of Initial Antiretroviral Treatment Regimens
Ep 2531027 B1
( 12 ) United States Patent
Lamivudine in Combination with Zidovudine, Stavudine, Or Didanosine in Patients with HIV-1 Infection
Recent Advances in Antiviral Therapy J Clin Pathol: First Published As 10.1136/Jcp.52.2.89 on 1 February 1999
AVT-080205-Ait-Khaled
This Project Has Been Supported with Unrestriced Grants from Abbvie Gilead Sciences HEXAL Janssen-Cilag MSD Viiv Healthcare By
Hiv Treatment Failure
219 = 141W94 (Amprenavir, Agenerase)
Literature References EMTRICITABINE/RILPIVIRINE
Guidelines for Antiretroviral Therapy for HIV Infection
Longitudinal Analysis of the Utility of Liver Biochemistry in Hospitalised COVID-19 Patients As Prognostic Markers
Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
Frequência De Factores De Risco Cardiovascular E Doença Cardíaca
Pdf Standard Procedure for Data Transfer
Stembook 2018.Pdf
Adolescent Adherence Questionnaire
Viroinformatics-Based Investigation of SARS-Cov-2 Core Proteins for Potential Therapeutic Targets
Top View
Putative HIV-1 Reverse Transcriptase Inhibitors: Design, Synthesis, in Vitro Evaluation and in Silico Analysis
Repurposing of FDA Approved Drugs
WO 2013/167743 Al 14 November 2013 (14.11.2013) P O P C T
Antiviral Drugs
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Patient Evaluation and Antiretroviral Treatment for Adults and Adolescents Clinical Protocol for the WHO European Region (2012 Revision)
Non-Nucleoside Reverse Transcriptase Inhibitors: the NNRTI Boom
Women's Interagency Hiv Study Drug List 1 – By
AVT040204-Gatell
HICDEP: HIV Cohorts Data Exchange Protocol
Table Hiv-1 Resistance to Rilpivirine in the Context Of
Amprenavir, Agenerase
Reverse Transcriptase
WO 2018/165198 Al 13 September 2018 (13.09.2018) W !P O PCT
WO 2018/206466 Al 15 November 2018 (15.11.2018) W ! P O PCT
Bioactive Compound Library Plus (96-Well)
Ln Compliance with the Canadian Privacy Legislation Sorne Supporting Forms May Have Been Removed from This Dissertation
Drug List 1-1005
Bioanalysis and Pharmacokinetics-Pharmacodynamics Εodeδing of the Endogenous Β'deoxynucδeoside Triphosphate Pool in Indivi
Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: a Combinatorial Approach
(12) United States Patent (10) Patent No.: US 8,703,801 B2 Nair Et Al
Human Immunodeficiency Virus
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2010/0029591 A1 STOFFELS (43) Pub
Non-Nucleoside Reverse Transcriptase Inhibitors In
WO 2017/017609 Al 2 February 2017 (02.02.2017) P O P C T
Inhibitor Potency and Oral Bioavailability 367 Acquired
(12) Patent Application Publication (10) Pub. No.: US 2008/0241289 A1 Gant Et Al
Us 2019 / 0127401 A1
Women's Interagency Hiv Study Drug List 1
Women=S Interagency Hiv Study Drug List 1 B by Alphabet
A Multivariate Analysis on Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors and Resistance Induced by Mutation
HIV-1 Nnrtis: Structural Diversity, Pharmacophore Similarity, and Implications for Drug Design